Ginkgo Bioworks Holdings (DNA)
Healthcare
Biotechnology
8.90 $
+10.5%
vs. previous close
Closing price · As of: 3. Aug 2026
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Ginkgo Bioworks Holdings (DNA) with date, type and a link to the original document.
No SEC filings are available for this stock yet.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.